{"title":"[Addiction in old age].","authors":"Irmgard Vogt, Martin Schmid","doi":"10.1055/a-2629-2014","DOIUrl":"https://doi.org/10.1055/a-2629-2014","url":null,"abstract":"<p><p>When we think of addiction, we don't automatically think of elderly people. Rather, we see young to middle-aged alcohol or drug addicts in our mind's eye. The following article shows that this is a misconception and also how important the topic of addiction is in old age - even if it is different for senior citizens.</p>","PeriodicalId":93975,"journal":{"name":"Deutsche medizinische Wochenschrift (1946)","volume":"150 20","pages":"1226-1236"},"PeriodicalIF":0.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145194082","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Tuberculosis - New perspectives in diagnosis and treatment].","authors":"Pia Hartmann","doi":"10.1055/a-2698-9661","DOIUrl":"https://doi.org/10.1055/a-2698-9661","url":null,"abstract":"","PeriodicalId":93975,"journal":{"name":"Deutsche medizinische Wochenschrift (1946)","volume":"150 20","pages":"1175-1176"},"PeriodicalIF":0.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145194112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Angela Klingmüller, Jonathan Steinke, Jan Rybniker, Isabelle Suárez
{"title":"[Extrapulmonary tuberculosis].","authors":"Angela Klingmüller, Jonathan Steinke, Jan Rybniker, Isabelle Suárez","doi":"10.1055/a-2597-9679","DOIUrl":"10.1055/a-2597-9679","url":null,"abstract":"<p><p>In 2023, tuberculosis (TB) caused 1.25 million deaths among 10.8 million cases, remaining the deadliest infectious disease worldwide. In Germany, incidence declined for decades but rose slightly in 2022-2023, driven mainly by migration from high-prevalence countries (e.g., Syria, Afghanistan, Ukraine). While most cases are pulmonary TB (PTB), 22.8% are extrapulmonary TB (EPTB), which can affect any organ and is often hard to diagnose due to nonspecific symptoms. Diagnosis uses microscopy, PCR, and culture; treatment typically lasts at least 6 months, extended for CNS, bone, or miliary TB. Treatment response is assessed clinically and radiologically; reliable blood-based markers are urgently needed.</p>","PeriodicalId":93975,"journal":{"name":"Deutsche medizinische Wochenschrift (1946)","volume":"150 20","pages":"1189-1196"},"PeriodicalIF":0.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145194114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Screening and Prevention of Chronic Viral Hepatitis].","authors":"Markus Cornberg, Lisa Sandmann","doi":"10.1055/a-2532-6320","DOIUrl":"https://doi.org/10.1055/a-2532-6320","url":null,"abstract":"<p><p>Chronic viral hepatitis, particularly chronic hepatitis B and C, is among the leading global causes of liver cirrhosis and hepatocellular carcinoma (HCC). Despite effective treatment options such as virus suppressive nucleos(t)ide analogues for HBV and curative direct acting antiviral therapies for HCV, many infections remain undetected. The WHO aims to eliminate hepatitis B and C as public health threats by 2030, targeting a 90% reduction in new infections and a 65% reduction in deaths. Germany supports these objectives through its BIS 2030 strategy, which emphasizes prevention, identification of at-risk groups, education, and treatment. A central component is screening to diagnose chronic infections early and initiate therapy promptly. This article summarizes practical current recommendations for the prevention and early detection of chronic viral hepatitis, with a particular focus on hepatitis B and hepatitis C, including complementary aspects regarding hepatitis D and hepatitis E in immunocompromised individuals.</p>","PeriodicalId":93975,"journal":{"name":"Deutsche medizinische Wochenschrift (1946)","volume":"150 21","pages":"1283-1292"},"PeriodicalIF":0.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145276981","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Julian P Kionke, Valentina L Müller, Alexander Kreuter
{"title":"[30-year-old patient with several spontaneously occurring lesions].","authors":"Julian P Kionke, Valentina L Müller, Alexander Kreuter","doi":"10.1055/a-2653-7137","DOIUrl":"https://doi.org/10.1055/a-2653-7137","url":null,"abstract":"","PeriodicalId":93975,"journal":{"name":"Deutsche medizinische Wochenschrift (1946)","volume":"150 21","pages":"1257-1258"},"PeriodicalIF":0.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145276955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Alexander Mischnik, Martin Kuhns, Lennard Meiwes, Steffen Pichlo, Julia Gaudlitz, Nika Zielinski, Thomas Theo Brehm
{"title":"[New methods of tuberculosis diagnostics].","authors":"Alexander Mischnik, Martin Kuhns, Lennard Meiwes, Steffen Pichlo, Julia Gaudlitz, Nika Zielinski, Thomas Theo Brehm","doi":"10.1055/a-2612-2417","DOIUrl":"10.1055/a-2612-2417","url":null,"abstract":"<p><p>Tuberculosis remains the leading cause of death by a single infectious agent worldwide, with over 10 million cases annually. Despite global efforts, delayed or missed diagnoses continue to fuel transmission and mortality, particularly in resource-limited settings. This review outlines both the current diagnostic standards - microscopy, culture, and nucleic acid amplification tests - and highlights promising innovations aimed at improving diagnosis of tuberculosis disease. Novel approaches include stool polymerase chain reaction (PCR), CRISPR (clustered regularly interspaced short palindromic repeats)-based detection of circulating cell-free DNA (cfDNA), transcriptomic signatures, molecular bacterial load assay (MBLA), lipoarabinomannan (LAM) detection in urine or sputum, and non-invasive sampling techniques using exhaled breath condensate, face masks or oral swabs. Furthermore, advancements in imaging technologies and AI (artificial intelligence)-based tools may enhance diagnostic accuracy. Together, these developments have the potential to accelerate and simplify tuberculosis diagnostics in the future.</p>","PeriodicalId":93975,"journal":{"name":"Deutsche medizinische Wochenschrift (1946)","volume":"150 20","pages":"1198-1206"},"PeriodicalIF":0.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145194137","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sibylle C Mellinghoff, Eyleen Reifarth, Claudia Paganini
{"title":"[Crisis as opportunity - The significance of crisis for moral development during medical training].","authors":"Sibylle C Mellinghoff, Eyleen Reifarth, Claudia Paganini","doi":"10.1055/a-2668-7256","DOIUrl":"https://doi.org/10.1055/a-2668-7256","url":null,"abstract":"<p><p>The process of becoming a medical specialist is a transformative phase with professional competence as well as personal development. This study examines the role of crisis in the moral development of physicians during their postgraduate training.Based on Carol Gilligan's ethics of care and interviews with 45 physicians in Germany, the study demonstrates that crises can be an opportunity for the reflection on ethical problems and of moral maturity.The results show that more than half of the participants experienced at least one crisis during their training that significantly impacted their emotional and professional balance. Main triggers were workload, challenging patient situations, and conflicts with supervisors. Women were more frequently affected. These crises not only led to professional changes such as job change or temporary career breaks but also influenced the physicians' self-conception and moral values. Profound ethical reflections and changes such as an increased awareness of compassion, and moral integrity were observed. Peer exchange proved to be an important resource in coping with these situations. Many respondents expressed a desire for more structural and institutional support.The study highlights the importance of ethical competencies and interpersonal care in medical training. By integrating ethics of care, physicians can grow not only professionally but also morally, thereby contributing to holistic patient care.</p>","PeriodicalId":93975,"journal":{"name":"Deutsche medizinische Wochenschrift (1946)","volume":"150 21","pages":"e50-e57"},"PeriodicalIF":0.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145276960","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Natascha Röhlen, Katharina Laubner, Jochen Seufert, Robert Thimme
{"title":"[Interdisciplinary strategies for the prevention and treatment of MASLD].","authors":"Natascha Röhlen, Katharina Laubner, Jochen Seufert, Robert Thimme","doi":"10.1055/a-2532-5919","DOIUrl":"https://doi.org/10.1055/a-2532-5919","url":null,"abstract":"<p><p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is one of the most common causes of liver cirrhosis and hepatocellular carcinoma. The severity of the metabolic syndrome and in particular type 2 diabetes are major risk factors for the progression of liver disease, but also for the frequent occurrence of cardiovascular complications. Patients therefore benefit in particular from an interdisciplinary treatment. This article provides an overview of recommended strategies for the prevention and treatment of MASLD.</p>","PeriodicalId":93975,"journal":{"name":"Deutsche medizinische Wochenschrift (1946)","volume":"150 21","pages":"1259-1266"},"PeriodicalIF":0.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145276962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Hepatocellular Carcinoma: from Screening to Therapy].","authors":"Laura Hölzen, Jens Marquardt, Carolin Zimpel","doi":"10.1055/a-2532-6269","DOIUrl":"https://doi.org/10.1055/a-2532-6269","url":null,"abstract":"<p><p>Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and a leading cause of cancer-related death worldwide. The incidence is increasing globally, primarily due to the rising prevalence of chronic liver diseases. While chronic viral hepatitis (HBV, HCV) and alcohol abuse have traditionally been considered the main risk factors, metabolic dysfunction-associated steatohepatitis (MASH) is increasingly gaining importance, especially in Western industrialized nations. In the vast majority of cases, HCC develops on the basis of liver cirrhosis. When cirrhosis is present, diagnosis can usually be reliably made through dynamic imaging techniques. However, despite established surveillance programs, most cases of HCC are often diagnosed only at advanced stages, which significantly limits therapeutic options. The treatment of HCC depends on tumor stage, overall health, and liver function of the affected patients. Selecting the appropriate therapy requires a multidisciplinary decision-making process. While curative options include resection, transplantation, and local ablation, advanced stages are managed with loco-regional therapies or systemic treatments. In recent years, the therapeutic spectrum has been significantly expanded by the introduction of immune checkpoint inhibitors. Particularly, immunotherapeutic combination therapies approved for first-line treatment have significantly improved the overall survival of patients with advanced HCC. Nevertheless, the prognosis remains unfavorable in many cases, highlighting the need for further research to identify predictive biomarkers and develop innovative therapies.</p>","PeriodicalId":93975,"journal":{"name":"Deutsche medizinische Wochenschrift (1946)","volume":"150 21","pages":"1276-1282"},"PeriodicalIF":0.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145276964","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}